Dr. Irena Dujmovic Basuroski, MD

Dr. Dujmovic Basuroski practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Dujmovic Basuroski's NPI, 1932637568, was assigned on May 26, 2017. Dr. Dujmovic Basuroski holds North Carolina license 2017-00131.

Dr. Dujmovic Basuroski's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Dujmovic Basuroski's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. Dr. Dujmovic Basuroski is also affiliated with UNC Health Rex. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Dujmovic Basuroski to 1 more hospital, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dujmovic Basuroski practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dujmovic Basuroski's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dujmovic Basuroski is licensed in North Carolina.

CMS data shows 263 Medicare services from Dr. Dujmovic Basuroski across 6 procedure codes in 2024, for 130 Medicare patients. Medicare paid $15,720 for them.

CMS counts 130 Medicare patients who saw Dr. Dujmovic Basuroski in 2024. The largest group is 65 to 74, with 56 patients. 72% of them have high blood pressure, and 62% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dujmovic Basuroski's median patient age at 63, with 67% women.

In 2024, Dr. Dujmovic Basuroski wrote 1,223 Medicare Part D claims for 184 patients. 84% of them were for generic drugs. CMS names the drug for 958 of them, across 32 drugs with 11 or more claims each, at $842,878 in total drug cost. In 2023, CMS named 933 claims across 35 drugs.

Dr. Dujmovic Basuroski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dujmovic Basuroski as offering telehealth.

Dmand AI links 8 papers to Dr. Dujmovic Basuroski, published from 2013 to 2025. 2024 was the busiest year, with 3. The most frequent topics are Multiple Sclerosis and Disease Progression. Dr. Dujmovic Basuroski has published most often in Acta Neurol Belg. Dr. Dujmovic Basuroski's most frequent co-authors are Anahit Cheluskin Mehrabyan, MD, Hesham Ahmed Abboud, MD and Ahmed Mohamed Taha Abdelhak, MBCHB.

CMS Open Payments shows 16 general payments to Dr. Dujmovic Basuroski from 5 drug and device companies from 2018 to 2024. Travel and lodging make up the largest share, 53% of the total. Celgene Corporation paid the most, $1,080. It also lists 24 research payments totaling $2,530 from 2019 to 2021.